ADPKD typically results from inactivating mutations in genes encoding either of two transmembrane proteins, polycystin-1 (PKD1 in humans, Pkd1 in mice) or polycystin-2 (PKD2/Pkd2). This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.